Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
The Premarketing Clinical Trial Safety module provides a framework and details around drug safety requirements for clinical trials for drugs in humans. This module provides information about safety and ethical safeguards in place to protect human subjects in clinical trials. The typical clinical process of pre-marketing development consists of two successive periods that complete each other. The first one or learning phase that investigates, and the second one or confirmatory phase that validates. The learning phase corresponds to the phases traditionally labelled I and II and the confirmatory phase covers the traditional late phase II and phase III. Premarketing studies will provide the details on individual case reporting and aggregate reporting requirements. Finally, the module will discuss risk assessment and the premarketing review of safety data in an application. Pharmacoepidemiology Researches invites an article to publish in the Journal of Pharmacovigilance and Pharmacoepidemiology. Pharmacovigilance and Pharmacoepidemiology is a scholarly journal maintaining high standards of Pharmacoepidemiology Researches.
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Premarketing Clinical Trial Safety, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Premarketing Clinical Trial Safety will appear here as matching content is published in Pharmacovigilance and Pharmacoepidemiology (ISSN: 2638-8235). Readers can also browse the journal archive and current issue for connected research.
